| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Macquarie tips 60% upside for this ASX 200 stock | ||
| Fr | 3 ASX 200 stocks storming higher in this week's falling market | ||
| Fr | This is what happens if you start taking superannuation seriously before 40 | ||
| Fr | Macquarie tips nearly 20% upside for this ASX All Ords consumer discretionary stock | ||
| Fr | Up 196% since April, why this ASX 200 tech stock still offers a 'substantial opportunity' | ||
| Fr | Macquarie tips more than 20% upside for this ASX lithium stock | ||
| Fr | Sell! Sell! Sell! This miner is way overvalued, one broker says | ||
| Fr | Macquarie names its top 2 ASX 200 REITs | ||
| Fr | Uranium fever! Why Macquarie just raised its price target on Boss Energy shares | ||
| Fr | Why Aeris Resources, Humm, Mayne Pharma, and Steadfast shares are sinking today | ||
| Fr | 2 ASX 200 growth shares I'm close to buying next | ||
| Fr | Why Cedar Woods, Newmont, ResMed, and Titomic shares are pushing higher today | ||
| Fr | After a solid start to the year, how high can Coles shares go? | ||
| Fr | Brokers name 3 ASX shares to buy today | ||
| Fr | All Ords drug maker's shares plunge 30% on takeover troubles | ||
| Fr | ASX 200 energy stock lifts off on $185 million news | ||
| Fr | What's Macquarie's new price target on Lynas Rare Earths shares? | ||
| Fr | ANZ Bank shares push higher despite $1.1b profit hit | ||
| Fr | ResMed shares charge higher on strong Q1 update | ||
| Fr | These 2 ASX industrials are sailing ahead on defence demand | ||
| Fr | $10,000 invested in Pro Medicus shares a year ago is now worth… | ||
| Fr | Which major insurance group's managing director has stepped aside pending an investigation | ||
| Do | Tabcorp, Life360 shares up 120% this year: What's next for these ASX 200 shares? | ||
| Do | The best ASX ETFs for long-term compounding wealth | ||
| Do | Market beating ASX 200 REIT holds AGM |